News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • After midterm losses, JD Vance published a postmortem and pitched a post‑Trump Republican agenda focused on economic nationalism and restrained foreign policy.
  • Vance blamed the Iran war for Republican midterm setbacks, highlighting geopolitical risks that could affect investor sentiment.
  • Analysts recommend buying Marvell after a pullback, citing expected AI‑driven ramps in 800G/1.6T optics and scale‑out switching.
  • ProShares Russell 2000 Dynamic Buffer ETF (RB) is touted as a tactical short due to weakening developed‑market demand and bearish technicals.
  • Nebius is pitched as a pullback buy conditional on proving revenue scale and predictable funding to avoid dilution and capex risk.
  • Several trade ideas are structured as mid‑term, 45‑trading‑day tactical plays, signaling short‑horizon positioning among traders.

Latest Articles

Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment

Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment

Alamar Biosciences announced publication of a pivotal study in The Lancet Neurology demonstrating the use of its NULISAseq CNS 120 panel to track diverse plasma biomarkers in Alzheimer's patients treated with anti-amyloid antibody therapy (lecanemab). The study highlights distinct biological pathways involved in amyloid clearance versus cognitive d…

Muse Is the Revenue Multiplier Meta Needed - Tactical Long Opportunity

Muse Is the Revenue Multiplier Meta Needed - Tactical Long Opportunity

Muse, Meta's new personal AI agent, is rapidly moving up app-store charts and is being integrated into AI glasses and core apps. This trade idea buys into the view that Muse will both generate subscription revenue and materially increase ad pricing by surfacing high-intent signals previously dominated by search and commerce platforms. Entry $777.44…

UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors

UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors

Clover Health announced the addition of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors. These appointments fill existing vacancies and bring valuable expertise in federal healthcare policy, Medicare Advantage, clinical medicine, and healthcare technology to the board. The move is expected to support Clover H…

PEDEVCO to Participate in Upcoming Investor Conferences

PEDEVCO to Participate in Upcoming Investor Conferences

PEDEVCO Corp., a publicly traded energy company focusing on oil and gas asset acquisition and development in the Rocky Mountain region, announced that its Interim President and CEO, along with its CFO, will be participating in two virtual investor conferences hosted by Lytham Partners and Noble Capital Markets. These presentations aim to update inv…

22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule

22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule

22nd Century Group, Inc. calls on U.S. policymakers and the FDA to finalize and implement the proposed reduced nicotine content standard for combustible tobacco products, which has been pending for over a year. The company supports the administration's efforts to accelerate authorizations for vape and nicotine pouch products but stresses that nicot…

Soybean Prices Slip as Markets Await Outcome of Xi Visit to Washington

Soybean Prices Slip as Markets Await Outcome of Xi Visit to Washington

Chicago soybean futures eased on Thursday as market participants waited for potential trade developments stemming from Chinese President Xi Jinping's state visit to the White House. Market attention centered on the diplomatic summit and an extension of a tariff-pausing arrangement, while export reports provided mixed signals for near-term demand.

Battalion Oil to Release Investor Presentation on Sept. 30

Battalion Oil to Release Investor Presentation on Sept. 30

Battalion Oil Corporation plans to release an updated investor presentation on September 30, 2026, highlighting its corporate overview, operational updates, capital structure, liquidity, and future outlook. The company aims to maintain transparent communication with shareholders as it lays out its strategy for value creation.

Ormat Selected for Approximately $35 Million in U.S. Department of Energy Funding to Advance EGS and Hydrothermal Development

Ormat Selected for Approximately $35 Million in U.S. Department of Energy Funding to Advance EGS and Hydrothermal Development

Ormat Technologies announced it has been selected for approximately $35 million in funding from the U.S. Department of Energy to advance two geothermal projects: an Enhanced Geothermal Systems project at Dixie Valley, Nevada, and a hydrothermal development project at Cove Fort, Utah. These awards aim to support innovative geothermal technologies an…

Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc filed Form 25 with the SEC to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq and to deregister these securities under the Exchange Act. The last trading day on Nasdaq is anticipated to be October 2, 2026, and deregistration will become effective approximately 90 days post-filing. The company plans to suspend …

Iridium Stockholders Approve Acquisition by Rocket Lab

Iridium Stockholders Approve Acquisition by Rocket Lab

Iridium Communications Inc. announced that its stockholders approved the planned acquisition by Rocket Lab Corporation, with approximately 99.6% of votes cast in favor representing 81.0% of outstanding shares. The transaction values Iridium shares at a notional $54.00 per share, combining Iridium’s global satellite network with Rocket Lab’s launch …

Archimedes Tech SPAC Partners II Co. Announces Effectiveness of Registration Statement and Date for Extraordinary General Meeting to Approve Proposed Business Combination with Forge Nano, Inc.

Archimedes Tech SPAC Partners II Co. Announces Effectiveness of Registration Statement and Date for Extraordinary General Meeting to Approve Proposed Business Combination with Forge Nano, Inc.

Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII) announced the SEC has declared effective its registration statement related to the proposed business combination with Forge Nano, a U.S.-based advanced materials and semiconductor equipment company. An Extraordinary General Meeting to approve the deal is scheduled for October 16, 2026. Upon closin…

Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors

Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors

Clover Health Investments, Corp. announced the addition of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., to its Board of Directors. These appointments fill two Board vacancies and bring diverse expertise covering healthcare policy, Medicare Advantage, clinical practice, and business to support the company's mission of improvi…

Meta's Muse: AI Breakthrough That Forces a Buy Reappraisal

Meta's Muse: AI Breakthrough That Forces a Buy Reappraisal

Meta's Muse rollout alters both the revenue runway and competitive dynamics. We upgrade the rating to a tactical buy: enter at $650.00, target $780.00, stop $560.00. The trade is driven by accelerating ad relevance, new commerce touchpoints, and a lower capital drag from Reality Labs as AI adoption scales. Risks include execution, regulation, and m…